SCHEMBL5924432

SCHEMBL5924432

CCCc1c[nH]c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924367 0.88 NOS2 (0.46)
SCHEMBL474833 0.86 KCNH2 (0.46)
SCHEMBL27661521 0.84 KCNH2 (0.48)
SCHEMBL27681192 0.84 KCNH2 (0.48)
SCHEMBL8521631 0.84 KCNH2 (0.48)
SCHEMBL18794910 0.84 KCNH2 (0.48)
Hydrochloric Acid SCHEMBL12821604 0.83 KCNH2 (0.47)
SCHEMBL4743718 0.82
SCHEMBL16579802 0.82 BACE1 (0.33)
Hydrochloric Acid SCHEMBL7957510 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017205769-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE PHARMACYCLICS LLC (US) 2017-11-30 WO disclosed
WO-2017205762-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE PHARMACYCLICS LLC (US) 2017-11-30 WO disclosed
WO-2017205766-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE PHARMACYCLICS LLC (US) 2017-11-30 WO disclosed
US-8653124-B2 Inhibition of bacterial biofilms with imidazole derivatives NORTH CAROLINA STATE UNIVERSITY (US) 2014-02-18 US disclosed
US-20060089316-A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof BROWN TRUMAN R 2006-04-27 US disclosed
US-5358960-A Stabilization of protein; aging resistance THE ROCKEFELLER UNIVERSITY (US) 1994-10-25 US disclosed